Sharma East India Hosp and Medical Research Ltd Intrinsic Value
SHARMEH · Healthcare Services · Current price ₹96
Is Sharma East India Hosp and Medical Research Ltd undervalued?
DocStoX estimates the fair value of Sharma East India Hosp and Medical Research Ltd at ₹65 per share, versus the current market price of ₹96. That puts the stock about -32.5% above our fair-value estimate, which we read as "Avoid". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹38), Relative P/E (₹131), Graham floor (₹42). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹38 (bear) to ₹65 (base) to ₹131 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
Margin of safety
Value investors demand a margin of safety — a discount to intrinsic value that protects against being wrong. At ₹96 versus an intrinsic value of ₹65, Sharma East India Hosp and Medical Research Ltd currently offers -32.5% of negative margin (i.e. a premium).
More on Sharma East India Hosp and Medical Research Ltd
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.